Heather Burnett

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Ejection Fraction

Renal Cell Carcinoma

Small Cell Lung Cancer

Top Venues

Future oncology (London, England)

Journal of medical economics

Advances in therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Conor Chandler, Heather Burnett, Kassandra Schaible, Vishnu Senthil, Masafumi Kato, Yuji Miura, Takahiro Osawa, Hiroji Uemura, Hiroyo Kuwabara
Cost-effectiveness analysis of cabozantinib compared with everolimus, axitinib, and nivolumab in subsequent line advanced renal cell carcinoma in Japan. Journal of medical economics (2023)
Allie Cichewicz, Tom Tencer, Komal Gupte-Singh, Sonya Egodage, Heather Burnett, Jinender Kumar
A Systematic Review of the Economic and Health-Related Quality of Life Impact of Advanced Therapies Used to Treat Moderate-to-Severe Ulcerative Colitis. Advances in therapy (2023)
Heather Burnett, Helena Emich, Christopher Carroll, Naomi Stapleton, Parthiv Mahadevia, Tracy Li
Epidemiological and clinical burden of EGFR Exon 20 insertion in advanced non-small cell lung cancer: A systematic literature review. PloS one 16 (3) (2021)
Ajibade O Ashaye, Heather Burnett, Seye Abogunrin, Hemangi Panchmatia, Olga Ovcinnikova, Mehul Dalal
The clinical and economic burden of peripheral T-cell lymphoma: a systematic literature review. Future oncology (London, England) (2021)